Stay updated on Upifitamab Rilsodotin+Carboplatin in Ovarian Cancer Clinical Trial
Sign up to get notified when there's something new on the Upifitamab Rilsodotin+Carboplatin in Ovarian Cancer Clinical Trial page.

Latest updates to the Upifitamab Rilsodotin+Carboplatin in Ovarian Cancer Clinical Trial page
- Check7 days agoChange DetectedSite revision updated from v3.4.3 to v3.5.0.SummaryDifference0.1%

- Check14 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3. This appears to be a routine version/UI update and does not modify study details or eligibility on the page.SummaryDifference0.1%

- Check21 days agoNo Change Detected
- Check28 days agoNo Change Detected
- Check42 days agoChange DetectedSite update deployed Revision v3.4.2 and removed the funding-lapse notice and Revision v3.4.1; these are administrative changes and do not affect study details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check49 days agoChange DetectedNotice about a lapse in government funding and a new site revision tag (v3.4.1) were added, while the previous revision tag (v3.4.0) was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check57 days agoChange DetectedAdded a Show glossary option and updated metadata labels to 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data' with revision v3.4.0; previous labels used 'met' lowercase and 'No FEAR Act data', and revision was v3.3.4.SummaryDifference0.2%

- Check71 days agoChange DetectedA new site revision label (Revision: v3.3.4) replaces the previous Revision: v3.3.3; this is a backend CMS update and does not affect the study content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Upifitamab Rilsodotin+Carboplatin in Ovarian Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Upifitamab Rilsodotin+Carboplatin in Ovarian Cancer Clinical Trial page.